Smith & Nephew is partnering with Imperial College London to develop better surgical techniques for knee injuries.
Mazor Robotics has met sales and marketing milestones in its partnership with Medtronic, picking up another $40 million.
RBM is, above all, an opportunity to practice mindfulness in collecting clinical trial data within the site- and patient-centric environment.
The FDA approved the integration of Tandem's touchscreen insulin pump and Dexcom's G5 CGM.
The Philips-HeartFlow deal follows earlier agreements with GE Healthcare and Siemens Healthineers.
Liquid biopsy player Exosome Diagnostics is partnering with CareFirst to create evidence development studies for the evaluation of its EvoDx tests.
The agreement will see Shire contribute to the development of features tailored to the needs of patients who have inhibitors.
GlaxoSmithKline and Propeller Health are expanding their R&D partnership, inked in 2015, into a commercial one.
Carl Zeiss Meditec announced its acquisition of Veracity Innovations and its cloud-based platform that provides physicians with quick and easy access to…
MiMedx is divesting Stability Biologics, its bone graft subsidiary, back to its shareholders as it “transitions” into a biopharmaceutical company.
IBM and JDRF will use machine learning to identify risk factors that cause the onset of Type 1 diabetes in children.